Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
ISRG Intuitive Surgical
269.720
-2.530-0.93%
Post Mkt Price
269.600
-0.120-0.04%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
-0.16% 151.3746 -5.58% 145.7093 -9.28% 147.2606 -15.20% 148.3575
Receivable Turnover(T)
-7.37% 7.9217 -9.24% 7.7533 -1.71% 7.5695 18.40% 7.9962
Inventory Turnover(T)
2.09% 2.7736 10.32% 2.9351 17.42% 2.9925 17.82% 2.9473
Fixed Assets Turnover(T)
-9.08% 3.0731 -4.73% 3.1718 7.94% 3.3168 8.12% 3.3067
Total Asset Rate(T)
0.22% 0.4671 -0.49% 0.4587 10.28% 0.4684 10.76% 0.4619
ROIC
-26.96% 11.939% -25.44% 12.359% 33.95% 14.773% 48.14% 15.174%
ROE
-26.46% 12.021% -24.29% 12.550% 17.46% 14.773% 33.70% 15.760%
ROA
-26.66% 10.521% -23.84% 11.034% 19.06% 13.037% 35.88% 13.789%
FCF to Sales
-48.83% 17.571% -32.59% 21.698% -15.31% 24.465% 15.89% 30.401%
FCF to Net Income
-30.08% 78.012% -11.92% 90.206% -21.56% 87.889% -5.53% 101.836%
Efficiency Ratios
ROE 5 Year Average
-- -- -- -- -- -- 1.53% 15.671%
ROA 5 Year Average
-- -- -- -- -- -- 1.32% 13.398%
Average 5 Years ROIC
-- -- -- -- -- -- 0.79% 15.245%
Profitability Ratios TTM
Gross Margin
-1.95% 67.767% -0.77% 68.165% 3.55% 68.842% 5.60% 69.325%
Operating Margin
-16.89% 27.052% -8.90% 28.484% 17.99% 30.687% 32.40% 31.891%
Net Margin
-26.82% 22.524% -23.46% 24.054% 7.96% 27.836% 22.67% 29.852%
EBITDA Margin
-14.57% 0.3262% -7.95% 0.3406% 12.05% 0.3614% 22.68% 0.3732%
R & D Expense Ratio
15.25% 13.380% 5.93% 12.860% -8.53% 12.220% -13.92% 11.750%
Sales Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Administration Expense Rate
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Financial Health Ratios
Total Assets to Common Equity
1.59% 115.157% 0.46% 113.992% -0.56% 113.023% -0.76% 113.897%
Current Ratio
-8.49% 5.1022 -10.58% 5.3553 -22.19% 5.2178 -25.95% 5.0834
Quick Ratio
-10.55% 4.289 -11.77% 4.5966 -22.96% 4.506 -27.07% 4.4563
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- -- -- -- -- 31.08% 15.311%
Revenue CAGR(5Y)
-- -- -- -- -- -- 25.75% 16.122%
Net Income CAGR(3Y)
-- -- -- -- -- -- -13.85% 14.758%
Net Income CAGR(5Y)
-- -- -- -- -- -- 46.46% 18.293%
FCF 1 Year Growth
-- -- -- -- -- -- 2,174.37% 51.832%
FCF CAGR(3Y)
-- -- -- -- -- -- 234.52% 20.904%
FCF CAGR(5Y)
-- -- -- -- -- -- 12.37% 11.909%
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
CEO: Dr. Gary S. Guthart,PhD
Market: NASDAQ
Listing Date: 06/13/2000
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist